CompletedNot applicableNCT06517836
Automated Screening Device to Detect MTMROP
Studying Retinopathy of prematurity
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Siloam Vision
- Principal Investigator
- John P Campbell, MD/MPHOregon Health and Science University
- Intervention
- iROP DL(device)
- Enrollment
- 1284 target
- Eligibility
- 2 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- Oregon Health and Sciences University, Portland, Oregon, United States
Collaborators
National Eye Institute (NEI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06517836 on ClinicalTrials.govOther trials for Retinopathy of prematurity
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07093255Safety, PK and PD of FLQ-101 in Premature NeonatesFELIQS INC.
- RECRUITINGNCT06612541Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of PrematurityVanderbilt University Medical Center
- ENROLLING BY INVITATIONNANCT07334652Pain and Comfort in the Examination of Retinopathy of PrematurityAtaturk University
- RECRUITINGNANCT06717412Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity TherapyWang Yusheng
- RECRUITINGNCT05558059Imaging Retinal Vasculature in Infant EyesDuke University
- ACTIVE NOT RECRUITINGNANCT06109285Validation of i-ROP DL to Detect More Than Mild ROPSiloam Vision
- RECRUITINGNCT06315556An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)Bayer
- RECRUITINGNANCT06694103The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy ExaminationSinem Basdemir